Medicare Enrolled
Dr. Jayaram Bharadwaj, M.D.
Hematology & Oncology · Anaheim, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bharadwaj from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bharadwaj?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bharadwaj
Dr. Jayaram Bharadwaj is a hematology & oncology specialist in Anaheim, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Bharadwaj performed 2,217 Medicare services across 835 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bharadwaj received a total of $17,089 from 87 pharmaceutical and/or device companies across 734 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bharadwaj is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 40% volume in CA
$17,089 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,217
Medicare services
Top 40% in CA for hematology & oncology
835
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~111 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
594 | $102 | $150 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
398 | $107 | $200 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
354 | $8 | $45 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
346 | $8 | $10 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
142 | $107 | $185 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
108 | $67 | $150 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
99 | $148 | $275 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
90 | $13 | $40 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
34 | $60 | $150 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
29 | $154 | $260 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
23 | $77 | $150 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.5% high complexity
4.1% medium
94.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$17,089
Total received (2018-2024)
Avg $2,441/year across 7 years
Top 23% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
87
Companies
734
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,050 (88.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,039 (11.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,545
2023
$2,731
2022
$2,454
2021
$1,426
2020
$556
2019
$2,088
2018
$3,289
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$333
Janssen Biotech, Inc.
$266
Eisai Inc.
$265
Bayer Healthcare Pharmaceuticals Inc.
$247
Daiichi Sankyo Inc.
$233
Takeda Pharmaceuticals U.S.A., Inc.
$226
Incyte Corporation
$224
Astellas Pharma US Inc
$203
Gilead Sciences, Inc.
$164
Exelixis Inc.
$164
ADC Therapeutics America, Inc.
$159
Merck Sharp & Dohme LLC
$155
PUMA BIOTECHNOLOGY, INC.
$141
BeiGene USA, Inc.
$127
Novartis Pharmaceuticals Corporation
$114
Alexion Pharmaceuticals, Inc.
$103
PFIZER INC.
$86
E.R. Squibb & Sons, L.L.C.
$83
EMD Serono, Inc.
$83
Genentech USA, Inc.
$80
SpringWorks Therapeutics, Inc.
$79
Celgene Corporation
$78
PharmaEssentia USA Corporation
$75
ABBVIE INC.
$74
Ipsen Biopharmaceuticals, Inc
$66
Lilly USA, LLC
$64
GlaxoSmithKline, LLC.
$59
Boehringer Ingelheim Pharmaceuticals, Inc.
$57
Deciphera Pharmaceuticals Inc.
$56
Mirati Therapeutics, Inc.
$55
Rigel Pharmaceuticals, Inc.
$49
Coherus Biosciences Inc.
$44
SOBI, INC
$42
GENZYME CORPORATION
$39
Regeneron Healthcare Solutions, Inc.
$33
Tempus AI, Inc
$29
Verity Pharmaceuticals Inc.
$28
Karyopharm Therapeutics Inc.
$24
Myriad Genetic Laboratories, Inc.
$20
Agios Pharmaceuticals, Inc.
$20
Geron Corporation
$20
Organon Llc
$18
TAIHO ONCOLOGY, INC.
$18
Cumberland Pharmaceuticals, Inc.
$17
JAZZ PHARMACEUTICALS INC.
$16
Janssen Pharmaceuticals, Inc
$10
Top 3 companies account for 19.0% of 2024 payments
All-time payments by company (2018-2024) ›
Seattle Genetics, Inc.
$1,539
AstraZeneca Pharmaceuticals LP
$1,029
Janssen Biotech, Inc.
$873
Incyte Corporation
$849
Celgene Corporation
$800
Amgen Inc.
$777
PFIZER INC.
$685
Novartis Pharmaceuticals Corporation
$561
Gilead Sciences, Inc.
$484
E.R. Squibb & Sons, L.L.C.
$440
Daiichi Sankyo Inc.
$437
Exelixis Inc.
$427
Genentech USA, Inc.
$421
Bayer Healthcare Pharmaceuticals Inc.
$408
Takeda Pharmaceuticals U.S.A., Inc.
$405
Regeneron Healthcare Solutions, Inc.
$384
Astellas Pharma US Inc
$368
Merck Sharp & Dohme LLC
$361
Eisai Inc.
$320
Merck Sharp & Dohme Corporation
$279
BeiGene USA, Inc.
$271
Bayer HealthCare Pharmaceuticals Inc.
$269
GENZYME CORPORATION
$268
EISAI INC.
$228
AbbVie, Inc.
$206
PUMA BIOTECHNOLOGY, INC.
$200
Pharmacyclics LLC, An AbbVie Company
$172
EMD Serono, Inc.
$167
ADC Therapeutics America, Inc.
$159
Lilly USA, LLC
$139
Ipsen Biopharmaceuticals, Inc
$135
Seagen Inc.
$135
Boehringer Ingelheim Pharmaceuticals, Inc.
$129
Mirati Therapeutics, Inc.
$120
Alexion Pharmaceuticals, Inc.
$117
Rigel Pharmaceuticals, Inc.
$107
Karyopharm Therapeutics Inc.
$96
PharmaEssentia USA Corporation
$91
Myovant Sciences Inc.
$90
Coherus Biosciences Inc.
$87
SOBI, INC
$82
Kite Pharma, Inc.
$81
AMAG Pharmaceuticals, Inc.
$80
Sumitomo Pharma America, Inc.
$80
SpringWorks Therapeutics, Inc.
$79
GlaxoSmithKline, LLC.
$75
Deciphera Pharmaceuticals Inc.
$75
TerSera Therapeutics LLC
$75
AVEO Pharmaceuticals, Inc.
$74
ABBVIE INC.
$74
Verity Pharmaceuticals Inc.
$73
Foundation Medicine, Inc.
$65
MorphoSys, US Inc.
$65
Helsinn Therapeutics (U.S.), Inc.
$64
Puma Biotechnology, Inc.
$63
JAZZ PHARMACEUTICALS INC.
$61
Organon LLC
$56
TAIHO ONCOLOGY, INC.
$53
Blueprint Medicines Corporation
$50
MEDIVATION FIELD SOLUTIONS LLC
$50
Acrotech Biopharma LLC
$47
Taiho Oncology, Inc.
$45
Agios Pharmaceuticals, Inc.
$42
Sobi, Inc
$40
TESARO, Inc.
$38
Stemline Therapeutics Inc.
$37
Epizyme, Inc.,
$34
Tempus AI, Inc
$29
TOLMAR Pharmaceuticals, Inc.
$29
Aveo Pharmaceuticals, Inc.
$28
Clovis Oncology, Inc.
$28
Pharmacyclics LLC, an AbbVie Company
$27
Mylan Institutional Inc.
$25
Array BioPharma Inc.
$23
AbbVie Inc.
$22
Myriad Genetic Laboratories, Inc.
$20
Geron Corporation
$20
Organon Llc
$18
ImmunoGen, Inc.
$18
Verastem, Inc.
$18
Cumberland Pharmaceuticals, Inc.
$17
Philips Electronics North America Corporation
$17
Teva Pharmaceuticals USA, Inc.
$15
Sanofi Pasteur Inc.
$14
Partner Therapeutics, Inc.
$13
Janssen Pharmaceuticals, Inc
$10
Secura Bio, Inc.
$8
Top 3 companies account for 20.1% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALOXI · AYVAKIT · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BOSULIF · BRUKINSA · Bavencio · Braftovi · CABOMETYX · CALQUENCE · CARVYKTI · CHANTIX · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · EVENITY · Elahere · Enhertu · FARYDAK · FERAHEME · FLUZONE HIGH-DOSE · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAUCHER-DISEASE · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Itovebi · JADENU · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · MEKINIST · MONJUVI · MVASI · MYLOTARG · MYRISK · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · RYBREVANT · RYDAPT · RYTELO · Revlimid · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SPRYCEL · SUTENT · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEPMETKO · TEVIMBRA · TIVDAK · Tavalisse · Tecentriq · Trelstar · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · Vectibix · Venclexta · Vitrakvi · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · ZEJULA · ZEPZELCA · ZOLADEX · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
328
Per 100K population
10.4
County median income
$113,702
Nearest hospital
AHMC ANAHEIM REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bharadwaj is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bharadwaj experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Bharadwaj performed 594 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bharadwaj receive payments from pharmaceutical companies?
Yes. Dr. Bharadwaj received a total of $17,089 from 87 companies across 734 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bharadwaj's costs compare to other hematology & oncology specialists in Anaheim?
Dr. Bharadwaj's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bharadwaj) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Anaheim
Browse hematology & oncology specialists in Anaheim ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Seattle Genetics, Inc. Payments to Doctors
See all physicians who received payments from Seattle Genetics, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology